(USNA) USANA Health Sciences - Ratings and Ratios

USANA Health Sciences Inc (NYSE:USNA) is a leading developer, manufacturer, and distributor of premium nutritional supplements, personal care products, and skincare solutions, operating globally across the Asia Pacific, the Americas, and Europe. The companys product portfolio is diversified across two primary business segments: Direct Selling and Hiya Direct-To-Consumer, catering to a wide range of customer needs.

The companys product offerings include a broad spectrum of nutritional supplements, such as USANA nutritional optimizers, Essentials/CellSentials, and food products designed for healthy weight management, digestive health, and energy and hydration. Additionally, USANA provides Celavive, a comprehensive skincare regimen tailored to various skin types and ethnicities, as well as other products and tools aimed at supporting associates in building their businesses and marketing efforts.

USANAs distribution strategy encompasses multiple channels, including retail customers, subscription models, direct selling, and online sales, allowing the company to effectively reach and serve its diverse customer base. The company has also established strategic research collaborations with reputable institutions, such as Beijing University of Chinese Medicine and the National Sports Training Bureau, to drive innovation and stay at the forefront of the industry.

From a technical analysis perspective, USANAs stock price has been trending below its 200-day Simple Moving Average (SMA), indicating a potential downtrend. However, the stocks current price is above its 20-day and 50-day SMAs, suggesting a short-term uptrend. The Average True Range (ATR) indicates a moderate level of volatility. Considering the , a potential trading opportunity may arise if the stock price breaks above its 52-week high or falls below its 52-week low.

Fundamentally, USANAs market capitalization stands at $528.83M USD, with a Price-to-Earnings (P/E) ratio of 15.41 and a Forward P/E of 10.68, indicating a relatively reasonable valuation. The companys Return on Equity (RoE) is 6.63%, suggesting a moderate level of profitability. By analyzing the , it is evident that USANAs financial performance is stable, with a reasonable valuation. Combining this with the , a forecast can be made that USANAs stock price may experience a rebound if the company reports strong earnings and the overall market sentiment improves.

Based on the analysis of both and , a potential forecast for USANAs stock price is a short-term increase towards $30.00, driven by a potential breakout above its current trading range. However, a sustained uptrend may require the company to demonstrate significant improvement in its financial performance and/or a shift in market sentiment. Conversely, a decline below $23.43 may signal a further downtrend.